Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Tota...(300790 236024 Total stockholders...)
| HOME >> BIOLOGY >> TECHNOLOGY |
300,790 236,024
Total stockholders' equity 702,259 570,208
Total liabilities and stockholders' equity $761,239 $623,839
Gen-Probe Incorporated
Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
Revenues:
Product sales $97,402 $83,470 $278,451 $239,811
Collaborative research
revenue 3,118 1,470 11,239 14,743
Royalty and license revenue 1,213 7,287 14,375 9,151
Total revenues 101,733 92,227 304,065 263,705
Operating expenses:
Cost of product sales 31,810 24,298 91,148 76,207
Research and development 27,582 24,178 72,813 63,833
Marketing and sales 9,651 9,526 28,580 27,533
General and administrative 11,380 12,748 34,742 34,104
Total operating expenses 80,423 70,750 227,283 201,677
Income from operations 21,310 21,477 76,782 62,028
Total other income, net 3,333 1,921 8,610 5,081
Income before income tax 24,643 23,398 85,392 67,109
Income tax expense 7,392 8,587 19,664 24,745
Net income $17,251 $14,811 $65,728 $42,364
Net income per share:
Basic $0.32 $0.29 $1.25 $0.82
Diluted
'/>"/>
| SOURCE Gen-Probe Incorporated Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |